相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Liposomal nanohybrid cerasomes targeted to PD-L1 enable dual-modality imaging and improve antitumor treatments
Yang Du et al.
CANCER LETTERS (2018)
Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties
Alyona Sukhanova et al.
NANOSCALE RESEARCH LETTERS (2018)
Dependence of Nanoparticle Toxicity on Their Physical and Chemical Properties
Alyona Sukhanova et al.
NANOSCALE RESEARCH LETTERS (2018)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
The Promise and Challenges of CAR-T Gene Therapy
Bridget M. Kuehn
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
FDA Approval of Tisagenlecleucel Promise and Complexities of a $475 000 Cancer Drug
Peter B. Bach et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma
Juliana Cano-Mejia et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
J. Bellmunt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers
Yang Liu et al.
SCIENTIFIC REPORTS (2017)
Personalized T cell-mediated cancer immunotherapy: progress and challenges
Michael T. Bethune et al.
CURRENT OPINION IN BIOTECHNOLOGY (2017)
Fast Image-Guided Stratification Using Anti-Programmed Death Ligand 1 Gold Nanoparticles for Cancer Immunotherapy
Rinat Meir et al.
ACS NANO (2017)
Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer
Jun Xu et al.
ACS NANO (2017)
Hydrogel dual delivered celecoxib and anti-PD-1 synergistically improve antitumor immunity
Yongkui Li et al.
ONCOIMMUNOLOGY (2016)
Different-Sized Gold Nanoparticle Activator/Antigen Increases Dendritic Cells Accumulation in Liver-Draining Lymph Nodes and CD8+T Cell Responses
Qianqian Zhou et al.
ACS NANO (2016)
Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy
Maria Stella Sasso et al.
BIOMATERIALS (2016)
Newly Emerging Theranostic Agents for Simultaneous Cancer-targeted Imaging and Therapy
Shenglin Luo et al.
CURRENT MEDICINAL CHEMISTRY (2016)
Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation
Shi-Yong Li et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer
Xiaopin Duan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy
Kuangda Lu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Howard L. Kaufman et al.
LANCET ONCOLOGY (2016)
Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
Chao Wang et al.
NANO LETTERS (2016)
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
Qian Chen et al.
NATURE COMMUNICATIONS (2016)
Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics
Lili Zou et al.
THERANOSTICS (2016)
In-Vivo Detection and Tracking of T Cells in Various Organs in a Melanoma Tumor Model by 19F-Fluorine MRS/MRI
Christine Gonzales et al.
PLOS ONE (2016)
Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT Imaging
Rinat Meir et al.
ACS NANO (2015)
New horizons in tumor microenvironment biology: challenges and opportunities
Fei Chen et al.
BMC MEDICINE (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice
Laura Jeanbart et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Nanoparticulate immunotherapy for cancer
Chintan H. Kapadia et al.
JOURNAL OF CONTROLLED RELEASE (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Targeting the TGFβ pathway for cancer therapy
Cindy Neuzillet et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
Naiyer A. Rizvi et al.
SCIENCE (2015)
Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells
Bonnie Huang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Ovarian Cancer Immunotherapy Using PD-L1 siRNA Targeted Delivery from Folic Acid-Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing
Pei Yun Teo et al.
ADVANCED HEALTHCARE MATERIALS (2015)
T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition
Roch Houot et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Delivery systems for siRNA drug development in cancer therapy
Cong-fei Xu et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Biopolymer implants enhance the efficacy of adoptive T-cell therapy
Sirkka B. Stephan et al.
NATURE BIOTECHNOLOGY (2015)
Non-Invasive In Vivo Imaging and Quantification of Tumor Growth and Metastasis in Rats Using Cells Expressing Far-Red Fluorescence Protein
Jon Christensen et al.
PLOS ONE (2015)
Adoptive T Cell Immunotherapy for Cancer
Karlo Perica et al.
RAMBAM MAIMONIDES MEDICAL JOURNAL (2015)
Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
Zhenghong Xu et al.
ACS NANO (2014)
Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity
Karlo Perica et al.
ACS NANO (2014)
Immunological Responses Triggered by Photothermal Therapy with Carbon Nanotubes in Combination with Anti-CTLA-4 Therapy to Inhibit Cancer Metastasis
Chao Wang et al.
ADVANCED MATERIALS (2014)
Adoptive Immunotherapy for Cancer or Viruses
Marcela V. Maus et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
pH-Sensitive nano-systems for drug delivery in cancer therapy
Juan Liu et al.
BIOTECHNOLOGY ADVANCES (2014)
Peptide-based cancer therapy: Opportunity and challenge
Dongdong Wu et al.
CANCER LETTERS (2014)
Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells
Tuan Hiep Tran et al.
CARBOHYDRATE POLYMERS (2014)
Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
Yong-Chen Lu et al.
CLINICAL CANCER RESEARCH (2014)
Multifunctional theranostic gold nanoparticles for targeted CT imaging and photothermal therapy
Taeyjuana Curry et al.
CONTRAST MEDIA & MOLECULAR IMAGING (2014)
Checkpoint blocking antibodies in cancer immunotherapy
Chrisann Kyi et al.
FEBS LETTERS (2014)
Exploiting the curative potential of adoptive T-cell therapy for cancer
Christian S. Hinrichs et al.
IMMUNOLOGICAL REVIEWS (2014)
CAR T cells: driving the road from the laboratory to the clinic
Eleanor J. Cheadle et al.
IMMUNOLOGICAL REVIEWS (2014)
Design and development of therapies using chimeric antigen receptor-expressing T cells
Gianpietro Dotti et al.
IMMUNOLOGICAL REVIEWS (2014)
Current advances in T-cell-based cancer immunotherapy
Mingjun Wang et al.
IMMUNOTHERAPY (2014)
Enhancement of All-Trans Retinoic Acid-Induced Differentiation by pH-Sensitive Nanoparticles for Solid Tumor Cells
Yongjian Wang et al.
MACROMOLECULAR BIOSCIENCE (2014)
Gold nanoparticle-mediated photothermal therapy: current status and future perspective
Sekyu Hwang et al.
NANOMEDICINE (2014)
Nanoscale artificial antigen presenting cells for T cell immunotherapy
Karlo Perica et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Enhancing endosomal escape for nanoparticle mediated siRNA delivery
Da Ma
NANOSCALE (2014)
A carbon nanotube-polymer composite for T-cell therapy
Tarek R. Fadel et al.
NATURE NANOTECHNOLOGY (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Molecular Imaging in Tracking Tumor-Specific Cytotoxic T Lymphocytes (CTLs)
Zhiyi Liu et al.
THERANOSTICS (2014)
Lipid nanoparticle delivery systems for siRNA-based therapeutics
C. Wan et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2014)
Carbon nanotubes for biomedical imaging: The recent advances
Hua Gong et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
Michal J. Besser et al.
CLINICAL CANCER RESEARCH (2013)
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
Liza B. John et al.
CLINICAL CANCER RESEARCH (2013)
New directions in quantum dot-based cytometry detection of cancer serum markers and tumor cells
Olga Akinfieva et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Latex bead-based artificial antigen-presenting cells induce tumor-specific CTL responses in the native T-cell repertoires and inhibit tumor growth
Chuanlai Shen et al.
IMMUNOLOGY LETTERS (2013)
Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64
Parijat Bhatnagar et al.
INTEGRATIVE BIOLOGY (2013)
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E. Bhola et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes
Yiran Zheng et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Human T Cells Engineered To Express a Programmed Death 1/28 Costimulatory Retargeting Molecule Display Enhanced Antitumor Activity
Chen Ankri et al.
JOURNAL OF IMMUNOLOGY (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Elimination of Metastatic Melanoma Using Gold Nanoshell-Enabled Photothermal Therapy and Adoptive T Cell Transfer
Adham S. Bear et al.
PLOS ONE (2013)
Cancer Nanomedicine: From Drug Delivery to Imaging
Edward Kai-Hua Chow et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Tracking immune cells in vivo using magnetic resonance imaging
Eric T. Ahrens et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Molecular mechanisms of T cell co-stimulation and co-inhibition
Lieping Chen et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
Matthias T. Stephan et al.
BIOMATERIALS (2012)
Positive conversion of negative signaling of CTLA4 potentiates antitumor efficacy of adoptive T-cell therapy in murine tumor models
Jae Hun Shin et al.
BLOOD (2012)
Aptamer-Mediated Blockade of IL4Rα Triggers Apoptosis of MDSCs and Limits Tumor Progression
Felix Roth et al.
CANCER RESEARCH (2012)
Management of Immune-Related Adverse Events and Kinetics of Response With Ipilimumab
Jeffrey S. Weber et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Targeted drug delivery for cancer therapy: the other side of antibodies
Michael A. Firer et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2012)
Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
Yuko Shirota et al.
JOURNAL OF IMMUNOLOGY (2012)
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
Jason Park et al.
NATURE MATERIALS (2012)
Parallel detection of antigen-specific T cell responses by combinatorial encoding of MHC multimers
Rikke Sick Andersen et al.
NATURE PROTOCOLS (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
A MOLECULAR IMAGING PRIMER: MODALITIES, IMAGING AGENTS, AND APPLICATIONS
Michelle L. James et al.
PHYSIOLOGICAL REVIEWS (2012)
Gold nanoparticles as computerized tomography (CT) contrast agents
Da Xi et al.
RSC ADVANCES (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Photodynamic Therapy of Cancer: An Update
Patrizia Agostinis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
A New Mechanism for Blocking Myeloid-Derived Suppressor Cells by CpG
Melissa G. Lechner et al.
CLINICAL CANCER RESEARCH (2011)
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
Tangying Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Inhibition of Tumor-Induced Myeloid-Derived Suppressor Cell Function by a Nanoparticulated Adjuvant
Audry Fernandez et al.
JOURNAL OF IMMUNOLOGY (2011)
The Suppressive Tumor Microenvironment: A Challenge in Cancer Immunotherapy
Elizabeth A. Vasievich et al.
MOLECULAR PHARMACEUTICS (2011)
Toxicological considerations of clinically applicable nanoparticles
Lara Yildirimer et al.
NANO TODAY (2011)
Noninvasive cell-tracking methods
Moritz F. Kircher et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
T cells enhance gold nanoparticle delivery to tumors in vivo
Laura C. Kennedy et al.
NANOSCALE RESEARCH LETTERS (2011)
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Padmanee Sharma et al.
NATURE REVIEWS CANCER (2011)
A Drug-Loaded Aptamer-Gold Nanoparticle Bioconjugate for Combined CT Imaging and Therapy of Prostate Cancer
Dongkyu Kim et al.
ACS NANO (2010)
Non-Invasive Cell Tracking in Cancer and Cancer Therapy
Hao Hong et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Breaking down the barriers: siRNA delivery and endosome escape
Monika Dominska et al.
JOURNAL OF CELL SCIENCE (2010)
Myeloid derived suppressor cells and their role in tolerance induction in cancer
Taku Fujimura et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2010)
Clustering of Stimuli on Single-Walled Carbon Nanotube Bundles Enhances Cellular Activation
Tarek R. Fadel et al.
LANGMUIR (2010)
Therapeutic cell engineering with surface-conjugated synthetic nanoparticles
Matthias T. Stephan et al.
NATURE MEDICINE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression
Li Yang et al.
TRENDS IN IMMUNOLOGY (2010)
FOXP3+ regulatory T cells in the human immune system
Shimon Sakaguchi et al.
NATURE REVIEWS IMMUNOLOGY (2010)
siRNA delivery systems for cancer treatment
Yu-Kyoung Oh et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
siRNA Conjugate Delivery Systems
Ji Hoon Jeong et al.
BIOCONJUGATE CHEMISTRY (2009)
In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells
Xiao-ling Lu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC)
Malarvizhi Durai et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko et al.
CLINICAL CANCER RESEARCH (2009)
Adoptive cell therapy for the treatment of patients with metastatic melanoma
Steven A. Rosenberg et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Antigen presentation on artificial acellular substrates: modular systems for flexible, adaptable immunotherapy
Erin R. Steenblock et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice
Hanh K. Le et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Quantum Dots for In Vivo Small-Animal Imaging
Laurent A. Bentolila et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Enhanced cellular activation with single walled carbon nanotube bundles presenting antibody stimuli
Tarek R. Fadel et al.
NANO LETTERS (2008)
Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer
Rachela Popovtzer et al.
NANO LETTERS (2008)
Nanoparticles for drug delivery in cancer treatment
Barbara Haley et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Tailoring T-cell receptor signals by proximal negative feedback mechanisms
Oreste Acuto et al.
NATURE REVIEWS IMMUNOLOGY (2008)
In vivo imaging of T cell delivery to tumors after adoptive transfer therapy
Mikael J. Pittet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Induction of tumor antigen-specific cytotoxic T cell responses in naive mice by latex microspheres-based artificial antigen-presenting cell constructs
Chuanlai Shen et al.
CELLULAR IMMUNOLOGY (2007)
Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell
Marcus O. Butler et al.
CLINICAL CANCER RESEARCH (2007)
The tumour microenvironment as a target for chemoprevention
Adriana Albini et al.
NATURE REVIEWS CANCER (2007)
RNAi therapeutics: a potential new class of pharmaceutical drugs
David Bumcrot et al.
NATURE CHEMICAL BIOLOGY (2006)
TGF beta inhibition for cancer therapy
Elise F. Saunier et al.
CURRENT CANCER DRUG TARGETS (2006)
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
Noweeda Mirza et al.
CANCER RESEARCH (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
T lymphocytes as potential therapeutic drug carrier for cancer treatment
U Steinfeld et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Transforming growth factor-beta in cancer and metastasis
Sonia B. Jakowlew
CANCER AND METASTASIS REVIEWS (2006)
Short interfering RNA (siRNA): tool or therapeutic?
D Cejka et al.
CLINICAL SCIENCE (2006)
Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration
S Kawakami et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ
Y Laouar et al.
NATURE IMMUNOLOGY (2005)
The ABCs of artificial antigen presentation
JV Kim et al.
NATURE BIOTECHNOLOGY (2004)
Artificial antigen-presenting constructs efficiently stimulate minor histocompatibility antigen-specific cytotoxic T lymphocytes
LEM Oosten et al.
BLOOD (2004)
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cells as vehicles for cancer gene therapy: The missing link between targeted vectors and systemic delivery?
K Harrington et al.
HUMAN GENE THERAPY (2002)
Spinning molecular immunology into successful immunotherapy
DM Pardoll
NATURE REVIEWS IMMUNOLOGY (2002)
Activation of antigen-specific T cells by artificial cell constructs having immobilized multimeric peptide-class I complexes and recombinant B7-Fc proteins
EL Tham et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
Malignant cells, directors of the malignant process: Role of transforming growth factor-beta
BA Teicher
CANCER AND METASTASIS REVIEWS (2001)
分享论文
